Additional Tyrosine Kinase Inhibitors in Renal Cell Carcinoma

Antiangiogenic tyrosine kinase inhibitors and immunotherapy as first-line treatment for metastatic renal cell carcinoma: is there an increased risk of hypothyroidism?

Therapeutic Advances in Urology ◽

10.1177/17562872211029784 ◽

2021 ◽

Vol 13 ◽

pp. 175628722110297

Author(s):

Giandomenico Roviello ◽

Sebastiano Buti ◽

Carlo Cattrini ◽

Alessia Mennitto ◽

Carlo Messina ◽

...

Keyword(s):

Renal Cell Carcinoma ◽

Tyrosine Kinase ◽

Cell Carcinoma ◽

Tyrosine Kinase Inhibitors ◽

Renal Cell ◽

Kinase Inhibitors ◽

Line Treatment ◽

First Line ◽

Increased Risk ◽

First Line Treatment

Download Full-text

Prognostic biomarkers for patients with advanced renal cell carcinoma treated with VEGF-targeted tyrosine kinase inhibitors

OncoTargets and Therapy ◽

10.2147/ott.s45872 ◽

2013 ◽

pp. 679 ◽

Cited By ~ 1

Author(s):

Daniel Cho

Keyword(s):

Renal Cell Carcinoma ◽

Tyrosine Kinase ◽

Cell Carcinoma ◽

Tyrosine Kinase Inhibitors ◽

Renal Cell ◽

Kinase Inhibitors ◽

Prognostic Biomarkers ◽

Advanced Renal Cell Carcinoma

Download Full-text

Can Tyrosine Kinase Inhibitors be Discontinued in Patients with Metastatic Renal Cell Carcinoma and a Complete Response to Treatment? A Multicentre, Retrospective Analysis

European Urology ◽

10.1016/j.eururo.2008.10.021 ◽

2009 ◽

Vol 55 (6) ◽

pp. 1430-1439 ◽

Cited By ~ 69

Author(s):

Manfred Johannsen ◽

Anne Flörcken ◽

Axel Bex ◽

Jan Roigas ◽

Marco Cosentino ◽

...

Keyword(s):

Renal Cell Carcinoma ◽

Tyrosine Kinase ◽

Cell Carcinoma ◽

Retrospective Analysis ◽

Tyrosine Kinase Inhibitors ◽

Metastatic Renal Cell Carcinoma ◽

Renal Cell ◽

Kinase Inhibitors ◽

Complete Response ◽

Response To Treatment

Download Full-text

Acquired Hypothyroidism as a Predictive Marker of Outcome in Patients With Metastatic Renal Cell Carcinoma Treated With Tyrosine Kinase Inhibitors: A Literature-Based Meta-Analysis

Clinical Genitourinary Cancer ◽

10.1016/j.clgc.2014.10.002 ◽

2015 ◽

Vol 13 (4) ◽

pp. 280-286 ◽

Cited By ~ 13

Author(s):

Andreas Nearchou ◽

Antonis Valachis ◽

Pehr Lind ◽

Olof Akre ◽

Per Sandström

Keyword(s):

Renal Cell Carcinoma ◽

Tyrosine Kinase ◽

Cell Carcinoma ◽

Tyrosine Kinase Inhibitors ◽

Metastatic Renal Cell Carcinoma ◽

Renal Cell ◽

Kinase Inhibitors ◽

Meta Analysis ◽

Predictive Marker

Download Full-text

PD57-08 TUMORAL CD8+ T CELLS CORRELATE WITH FAVORABLE OUTCOME IN METASTATIC RENAL CELL CARCINOMA TREATED WITH TYROSINE KINASE INHIBITORS

The Journal of Urology ◽

10.1016/j.juro.2018.02.2652 ◽

2018 ◽

Vol 199 (4S) ◽

Author(s):

Jiajun Wang ◽

Li Liu ◽

Wei Xi ◽

Jiejie Xu ◽

Jianming Guo

Keyword(s):

Renal Cell Carcinoma ◽

T Cells ◽

Tyrosine Kinase ◽

Cell Carcinoma ◽

Tyrosine Kinase Inhibitors ◽

Metastatic Renal Cell Carcinoma ◽

Cd8 T Cells ◽

Renal Cell ◽

Kinase Inhibitors ◽

Favorable Outcome

Download Full-text

Tumor-infiltrating neutrophils predict therapeutic benefit of tyrosine kinase inhibitors in metastatic renal cell carcinoma

OncoImmunology ◽

10.1080/2162402x.2018.1515611 ◽

2018 ◽

Vol 8 (1) ◽

pp. e1515611

Author(s):

Jiajun Wang ◽

Li Liu ◽

Qi Bai ◽

Chenzhang Ou ◽

Ying Xiong ◽

...

Keyword(s):

Renal Cell Carcinoma ◽

Tyrosine Kinase ◽

Cell Carcinoma ◽

Tyrosine Kinase Inhibitors ◽

Metastatic Renal Cell Carcinoma ◽

Renal Cell ◽

Kinase Inhibitors ◽

Therapeutic Benefit

Download Full-text

Second-Generation Tyrosine Kinase Inhibitors (Pazopanib) in Renal Cell Carcinoma: Current Status

Renal Cell Carcinoma ◽

10.1007/978-1-4939-1622-1_9 ◽

2014 ◽

pp. 207-216

Author(s):

Linda Cerbone ◽

Cora N. Sternberg

Keyword(s):

Renal Cell Carcinoma ◽

Tyrosine Kinase ◽

Cell Carcinoma ◽

Tyrosine Kinase Inhibitors ◽

Renal Cell ◽

Second Generation ◽

Kinase Inhibitors ◽

Current Status

Download Full-text

Treatable causes of diarrhoea in patients on tyrosine kinase inhibitors for metastatic renal cell carcinoma

Annals of Oncology ◽

10.1093/annonc/mdy469 ◽

2019 ◽

Vol 30 (1) ◽

pp. 150-151

Author(s):

S.V. Lightowlers ◽

B. Greef ◽

T. Eisen ◽

A. Matakidou ◽

K. Fife ◽

...

Keyword(s):

Renal Cell Carcinoma ◽

Tyrosine Kinase ◽

Cell Carcinoma ◽

Tyrosine Kinase Inhibitors ◽

Metastatic Renal Cell Carcinoma ◽

Renal Cell ◽

Kinase Inhibitors

Download Full-text

Tyrosine Kinase Inhibitors for Metastatic Renal Cell Carcinoma - What Should We Tell Our Patients?

International Journal of Surgery ◽

10.1016/j.ijsu.2017.08.062 ◽

2017 ◽

Vol 47 ◽

pp. S8

Author(s):

J. Cobley ◽

G. Broadley ◽

F. Khan ◽

K. Harvey ◽

C. Parry ◽

...

Keyword(s):

Renal Cell Carcinoma ◽

Tyrosine Kinase ◽

Cell Carcinoma ◽

Tyrosine Kinase Inhibitors ◽

Metastatic Renal Cell Carcinoma ◽

Renal Cell ◽

Kinase Inhibitors

Download Full-text

Adjuvant tyrosine kinase inhibitors for renal cell carcinoma? No, thank you (at least for the present)

Future Oncology ◽

10.2217/fon-2018-0304 ◽

2018 ◽

Vol 14 (22) ◽

pp. 2223-2224 ◽

Cited By ~ 2

Author(s):

Alessandro Leonetti ◽

Teresa Zielli ◽

Sebastiano Buti

Keyword(s):

Renal Cell Carcinoma ◽

Tyrosine Kinase ◽

Cell Carcinoma ◽

Tyrosine Kinase Inhibitors ◽

Renal Cell ◽

Kinase Inhibitors

Download Full-text